Claus Juan San Pedro Moller's most recent trade in Y-Mabs Therapeutics Inc was a trade of 230,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 14, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Y-Mabs Therapeutics Inc | Claus Juan San Pedro Moller | Director, Director and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 230,000 | 230,000 | - | - | Employee Stock Option (right to buy) | |
Y-Mabs Therapeutics Inc | Claus Juan San Pedro Moller | Director, Director and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 226,800 | 226,800 | - | - | Employee Stock Option (right to buy) | |
Y-Mabs Therapeutics Inc | Claus Juan San Pedro Moller | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.27 per share. | 02 Dec 2020 | 40,734 | 616,569 (1%) | 0% | 51.3 | 2,088,245 | Common Stock |
Y-Mabs Therapeutics Inc | Claus Juan San Pedro Moller | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.98 per share. | 02 Dec 2020 | 9,266 | 607,303 (1%) | 0% | 51.0 | 472,377 | Common Stock |
Y-Mabs Therapeutics Inc | Claus Juan San Pedro Moller | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.02 per share. | 13 May 2020 | 139,154 | 657,303 (1%) | 0% | 36.0 | 5,012,995 | Common Stock |
Y-Mabs Therapeutics Inc | Claus Juan San Pedro Moller | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.75 per share. | 13 May 2020 | 60,846 | 796,457 (2%) | 0% | 37.8 | 2,297,125 | Common Stock |